
Read Gene Spolka Akcyjna
RDG | WAR
Overview
Corporate Details
- ISIN(s):
- PLRADGN00014 (+1 more)
- LEI:
- 2594003D7O7NDUV8GE29
- Country:
- Poland
- Address:
- Dobra Grzepnica-Alabastrowa 8, 72-003 Dobra
- Website:
- http://www.read-gene.com
- Sector:
- Health Care
- Industry:
- Health Care Technology
Description
Read Gene Spolka Akcyjna is at the forefront of innovative genetics, focusing on the commercialization of groundbreaking methods for detecting, preventing, and treating various forms of malignant tumors. Our cutting-edge DNA testing offers precise profiling to identify individuals’ genetic predispositions to cancer, enabling earlier treatment interventions. We collaborate closely with the International Center for Hereditary Cancers at the Pomeranian Medical University, leveraging the expertise of renowned scientists led by Prof. Jan Lubiński. Committed to scientific advancement and patient care, we continually strive to set new standards in genetic testing and personalized medicine. Join us in our mission to transform cancer care through innovation and research.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
No filings match the current criteria. |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1SPATIAL PLC | United Kingdom | SPA | |
![]() |
aap Implantate AG | Germany | AAQ1 | |
![]() |
ABL Diagnostics | France | ABLD | |
|
AddLife | Sweden | ALIF | |
|
Aiforia Technologies Oyj | Finland | AIFORI | |
![]() |
Aino Health AB (publ) | Sweden | AINO | |
![]() |
Almirall S.A. | Spain | ALM | |
![]() |
AMA Corporation PLC Corporation | United Kingdom | ALAMA | |
|
Amplifon | Italy | AMP | |
![]() |
Amplitude Surgical | France | AMPLI |